Merck (NYSE: MRK) announced results from new analyses from the IMPROVE-IT study.“IMPROVE-IT presents us with the opportunity to look at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE